iBio, Inc. - Common Stock, par value $0.001 per share (IBIO) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2023 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
IBIO on Nasdaq
Shares outstanding
24,040,200
Price per share
$2.54
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
3,569,988
Total reported value
$2,955,323
% of total 13F portfolios
0%
Share change
+365,879
Value change
+$299,071
Number of holders
32
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of iBio, Inc. - Common Stock, par value $0.001 per share (IBIO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Point72 Asset Management, L.P. 9.9% $9,716,600 14,289,118 Point72 Asset Management, L.P. 22 Aug 2025
Vestal Point Capital, LP 9.9% $3,518,752 4,275,000 Vestal Point Capital, LP 30 Sep 2025
Affinity Asset Advisors, LLC 10% 0% $4,627,194 +$424,252 2,401,616 +10% Affinity Asset Advisors, LLC 22 Jan 2026
Cormorant Asset Management, LP 10% $1,850,337 2,248,010 Cormorant Asset Management, LP 30 Sep 2025
EcoR1 Capital, LLC 9.9% $2,673,600 2,228,000 EcoR1 Capital, LLC 10 Dec 2025
Adage Capital Management, L.P. 10% $1,795,528 2,181,422 Adage Capital Management, L.P. 30 Sep 2025
SILVERARC CAPITAL MANAGEMENT, LLC 10% $1,795,528 2,181,422 SilverArc Capital Management, LLC 30 Sep 2025
Logos Global Management LP 8.9% $2,400,000 2,000,000 Logos Global Management LP 12 Dec 2025
Frazier Life Sciences Public Fund, L.P. 8.7% $2,344,160 1,953,467 Frazier Life Sciences Public Fund, L.P. 09 Dec 2025
ADAR1 Capital Management, LLC 9.9% -0.9% $1,507,006 +$586,394 1,794,055 +64% ADAR1 Capital Management, LLC 30 Jun 2025
INTEGRATED CORE STRATEGIES (US) LLC 5.2% $2,381,068 1,235,827 Millennium Management LLC 15 Jan 2026
Ikarian Capital, LLC 5% $947,430 1,151,051 Ikarian Capital, LLC 30 Sep 2025
Crutcher Patrick J 3.1% -56% $635,283 +$112,748 847,044 +22% Patrick J. Crutcher 30 Jun 2025
Opaleye Management Inc. 7.6% $787,500 750,000 Opaleye Management, Inc. 31 Dec 2024

As of 30 Sep 2025, 32 institutional investors reported holding 3,569,988 shares of iBio, Inc. - Common Stock, par value $0.001 per share (IBIO). This represents 15% of the company’s total 24,040,200 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of iBio, Inc. - Common Stock, par value $0.001 per share (IBIO) together control 15% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Lynx1 Capital Management LP 4.4% 1,055,897 -31% 0.18% $874,072
Ikarian Capital, LLC 2.6% 617,327 +2.9% 0.12% $511,023
AMERIPRISE FINANCIAL INC 2% 482,300 0% $399,248
Opaleye Management Inc. 1.6% 375,000 0% 0.04% $310,425
VANGUARD GROUP INC 1.1% 274,070 +91% 0% $226,930
BOOTHBAY FUND MANAGEMENT, LLC 0.74% 176,862 +11% 0% $146,406
GEODE CAPITAL MANAGEMENT, LLC 0.63% 151,309 +35% 0% $125,253
CITADEL ADVISORS LLC 0.55% 131,958 0% $109,235
TWO SIGMA SECURITIES, LLC 0.19% 45,079 +58% 0.01% $37,316
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.18% 44,471 0% $36,813
BlackRock, Inc. 0.18% 42,727 0% 0% $35,369
Virtu Financial LLC 0.17% 41,900 +4.3% 0% $35,000
HRT FINANCIAL LP 0.14% 34,157 0% $28,000
STATE STREET CORP 0.14% 33,699 0% 0% $27,896
ADAR1 Capital Management, LLC 0.11% 27,000 -51% 0% $22,351
NORTHERN TRUST CORP 0.1% 23,044 0% 0% $19,076
Balyasny Asset Management L.P. 0.04% 10,400 0% $8,609
Tower Research Capital LLC (TRC) 0.01% 1,733 -18% 0% $1,435
OSAIC HOLDINGS, INC. 0% 704 0% 0% $575
BANK OF AMERICA CORP /DE/ 0% 145 -7.6% 0% $120
Arax Advisory Partners 0% 91 0% 0% $76
MORGAN STANLEY 0% 57 +16% 0% $47
SBI Securities Co., Ltd. 0% 22 -90% 0% $18
SOA Wealth Advisors, LLC. 0% 13 0% 0% $11
BNP PARIBAS FINANCIAL MARKETS 0% 5 0% 0% $4

Institutional Holders of iBio, Inc. - Common Stock, par value $0.001 per share (IBIO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,318,875 $2,565,589 +$2,036,554 $1.93 9
2025 Q3 3,569,988 $2,955,323 +$299,071 $0.83 32
2025 Q2 3,204,109 $2,444,153 -$225,284 $0.76 30
2025 Q1 2,587,118 $10,399,905 +$550,651 $4.02 33
2024 Q4 2,612,402 $6,400,381 +$11,561 $2.45 29
2024 Q3 2,607,512 $5,788,674 +$356,141 $2.22 31
2024 Q2 2,451,117 $5,171,853 -$1,674,085 $2.11 26
2024 Q1 2,885,311 $11,469,753 +$10,566,308 $4.06 26
2023 Q4 251,385 $344,588 +$344,585 $1.37 20
2023 Q3 0 $0 -$5 $2.54 0
2023 Q2 8 $5 $0.62 1
2023 Q1 8 $17 +$17 $2.12 1